EGFR and non-small cell lung carcinoma: For advanced EGFR-mutated NSCLC patients who experienced small cell transformation after previous EGFR-TKI treatments, chemotherapy with platinum-based regimens combined with etoposide is recommended if the patient has acceptable performance status (44).